Drug combinations of rapamycin and AICAR increased tumor cell apoptosis, decreased cell proliferation, and sharply decreased Akt phosphorylation and HIF‐2α in ccRCC as well as VEGF in tumors compared with single‐drug treatment. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.